CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-13 Cr | ₹99 Cr | ₹66 Cr | ₹154 Cr |
What is the latest Net Current Assets ratio of CORONA REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹154 Cr |
How is Net Current Assets of CORONA REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹99 Cr | 51.06 | |
| Mar2024 | ₹66 Cr | -57.35 | |
| Mar2023 | ₹154 Cr | - | |
Compare Net Current Assets of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹13,121.6 Cr | 3% | 3.7% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 3% |
3.7% |
|
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses